Cost-effectiveness of Secukinumab compared to current treatments for the treatment of moderate to severe plaque Psoriasis in Canada
May 1, 2015, 00:00 AM
10.1016/j.jval.2015.03.1051
https://www.valueinhealthjournal.com/article/S1098-3015(15)01108-0/fulltext
Section Title :
Sensory Systems Disorders
Section Order :
509
First Page :
A182
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01108-0&doi=10.1016/j.jval.2015.03.1051